376 related articles for article (PubMed ID: 34379442)
1. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
[TBL] [Abstract][Full Text] [Related]
2. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
[TBL] [Abstract][Full Text] [Related]
3. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
[TBL] [Abstract][Full Text] [Related]
5. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
[TBL] [Abstract][Full Text] [Related]
6. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
[TBL] [Abstract][Full Text] [Related]
7. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
[TBL] [Abstract][Full Text] [Related]
9. Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
Sharma S; McMillan MT; Doucette A; Cohen RB; Berman A; Levin W; Simone CB; Shabason J
Clin Lung Cancer; 2018 May; 19(3):260-269.e3. PubMed ID: 29358031
[TBL] [Abstract][Full Text] [Related]
10. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
[TBL] [Abstract][Full Text] [Related]
11. Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation.
Zhao L; Shen Y; Guo JD; Gu HL; Yu W; Wang JM; Lv CX; Liu J; Cai XW; Fu XL
Radiat Oncol; 2017 Jul; 12(1):118. PubMed ID: 28709456
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.
Zeng H; Hendriks LEL; van Geffen WH; Witlox WJA; Eekers DBP; De Ruysscher DKM
Cancer Treat Rev; 2020 Aug; 88():102025. PubMed ID: 32512415
[TBL] [Abstract][Full Text] [Related]
13. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer.
Eaton BR; Kim S; Marcus DM; Prabhu R; Chen Z; Ramalingam SS; Curran WJ; Higgins KA
Cancer; 2013 Nov; 119(21):3753-60. PubMed ID: 23921891
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.
Chen Y; Li J; Hu Y; Zhang Y; Lin Z; Zhao Z; Jiao S
Strahlenther Onkol; 2016 Dec; 192(12):905-912. PubMed ID: 27605237
[TBL] [Abstract][Full Text] [Related]
15. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic cranial irradiation in small cell lung cancer: a single institution experience.
Naidoo J; Kehoe M; Sasiadek W; Hacking D; Calvert P
Ir J Med Sci; 2014 Mar; 183(1):129-32. PubMed ID: 23760883
[TBL] [Abstract][Full Text] [Related]
17. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH
JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532
[TBL] [Abstract][Full Text] [Related]
18. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
Gondi V; Paulus R; Bruner DW; Meyers CA; Gore EM; Wolfson A; Werner-Wasik M; Sun AY; Choy H; Movsas B
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):656-64. PubMed ID: 23597420
[TBL] [Abstract][Full Text] [Related]
19. Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients.
Cho Y; Lee J; Lee IJ; Kim JW; Baek JG; Jung DM; Cho BC; Hong MH; Kim HR; Lee CG; Yoon HI
Sci Rep; 2021 Apr; 11(1):7435. PubMed ID: 33795826
[TBL] [Abstract][Full Text] [Related]
20. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
